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A im: To evaluate voice outcomes in patients with 
early glottic carcinoma treated by CO
2
 laser cordectomy. 
Method: 15 patients with glottic Tis and T1 squamous 
cell carcinoma treated with CO
2
 laser were analyzed. The 
assessment consisted of perceptual voice analysis, objective 
voice evaluation and video-laryngo-stroboscopic exam. In 
addition, patients rated their voices and completed the Voice 
related Quality of Life (VR-QOL) questionnaire. The results 
were compared with those obtained in a matched control 
group. Results: Most of the patients presented some degree 
of hoarseness on perceptual voice analysis, mainly rough 
and breathy voices. Their acoustic evaluation compared with 
the control group showed a small increase in fundamental 
frequency, but with no statistically significant difference, 
and the values of jitter, shimmer and noise to harmonic ratio 
were worse and statistically significant. As regards to video-
laryngo-stroboscopic findings, better results were achieved 
in the less extensive resection group. Patients have had 
minimal repercussion in their life quality in respect to voice. 
Conclusions: In spite of voice alterations in patients submitted 
to cordectomy by CO
2
 laser, functional results are acceptable, 
with minimal repercussion in their quality of life.
Avaliação da voz em pacientes submetidos à cordectomia 
com laser de CO
2
.
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INTRODUCTION
Cancer of the larynx is the second most frequent 
tumor of the upper airway and upper digestive tract, sec-
ond only to oral cavity tumors. Brazil occupies the second 
place in the world in the incidence of cancer of the larynx. 
This disease affects mostly males in the sixth and seventh 
decades of life1. Most of the malignant tumors of the larynx 
(95%) are squamous cell carcinomas (SCCs) which belong 
to the epithelial lineage2.
Initial glottic carcinomas, classified as in situ car-
cinomas (Tis) and T1, may be treated by open surgery 
(cervical access), radiotherapy and laryngeal microsurgery 
with conventional instruments or by CO
2
 laser. These 
approaches provide satisfactory local control and similar 
survival rates3-5.
Cordectomy is the surgical procedure used for early 
glottic tumors, where the affected vocal fold is resected 
at varying depths.
Since Strong & Jako introduced CO
2
 laser in laryn-
geal surgery in 19727, this therapeutic strategy has gained 
worldwide acceptance for the treatment of laryngeal tu-
mors, particularly for early glottic tumors3,4,8-15.
Cure rates for CO
2
 laser treated patients with early 
glottic tumors vary from 89% to 100%4,14,16-18 and are similar 
to radiotherapy cure rates19,20.
The advantages of CO
2
 laser compared to other 
treatment strategies include lower morbidity compared to 
radiotherapy side effects (mucositis, xerostomia and dental 
problems), lower cost as patients do not require traqueos-
tomy, improved homeostasis, and the fact that CO
2
 laser 
does not exclude other forms of treatment if the disease 
recurs locally, regionally or at a distance5,19.
When different treatment strategies offer similar cure 
rates, resulting voice quality becomes paramount in the 
therapeutic decision. There are few published papers in 
medical literature about voice following laser cordectomy 
for the treatment of laryngeal tumors.
Most of the studies compare cordectomy with radio-
therapy, and results are controversial. Some authors have 
reported worse outcomes in patients undergoing laser 
surgery, which may limit its use21-23. Other studies, how-
ever, have stated that voice quality in patients undergoing 
CO
2
 laser cordectomy is similar to that in radiotherapy 
patients24-27.
CO
2
 laser cordectomy provides improved results in 
the voice quality of patients, compared to conventional 
cordectomy28-30. Few studies specifically on voice assess-
ment in patients that have undergone CO
2
 laser cordectomy 
have been published to date.
The factors that stimulated this study where the 
importance of preserving the phonatory function when 
treating early glottic tumors and the lack of guidelines on 
voice quality in patients undergoing CO
2
 laser cordectomy 
for the treatment of laryngeal tumors.
Therefore, the aim of this study was to assess voice 
quality in patients with stages Tis and T1 glottic carcinoma 
undergoing CO
2
 laser cordectomy.
METHODS
Between January and May 2004 we assessed fifteen 
patients (12 males and 3 females) who had undergone 
CO
2
 laser cordectomy for the treatment of early vocal fold 
SCC. Early glottic SCC was defined in this study as patients 
with vocal fold Tis and T1 tumors. Patients were referred 
to us from the Head and Neck Surgery Unit at Sao Paulo 
University - Paulista School of Medicine.
Ages varied from 43 to 82 years, average 63.1 years. 
Average follow-up time was 14.6 months, varying from 3 
to 38 months.
Patients were staged, based on data in their charts, 
using the clinical classification of the International Union 
Against Cancer (UICC) and the American Joint Committee 
on Cancer (AJCC) 2002.
Three patients were staged as TisN0 and twelve 
as T1aN0. Types of cordectomy were classified into five 
types according to the European Laryngological Society6 
guidelines, namely type I - sub-epithelial resection, type 
II - subligamentar resection, type III - transmuscular resec-
tion, type IV - total cordectomy, and type V - extended 
cordectomy. Type V is subdivided into Va (resection of 
part of the contra-lateral vocal fold), Vb (resection of the 
arytenoid), Vc (resection of the ventricular band), and Vd 
(resection of part of the subglottis). Three patients under-
went type I cordectomy (Tis), five patients underwent type 
II cordectomy, four patients underwent type III cordec-
tomy, and three patients underwent type IV cordectomy. 
No patient required type V cordectomy.
Surgery was done under general anesthesia. A 
400mm lens microscope was coupled to a Visograf® CO
2
 
laser unit. A 5 to 7 Watts superpulse mode 0.5 mm spot 
was used. Safety margins were 1 to 2mm. Following tu-
mor resection upper, lower, anterior, posterior and deep 
margins were sent to frozen section examination, to assure 
surgical safety margins.
All patients included in this study had been operated 
at least three months before enrollment, and were referred 
to post-operative speech therapy. No patient showed signs 
of local and/or regional recurrence and none had a second 
primary tumor.
Patients underwent subjective and objective voice 
assessment and videolaryngostroboscopic evaluation be-
tween the 3rd and 38th post-operative month. Subjective 
testing was done by perceptive-auditory voice analysis 
according to the GRBASI scale32, Sittel et al’s (1998)33 
general voice assessment numerical scale and Behlau’s35,36 
Portuguese adaptation of Hogikyan & Sethuraman’s (1999) 
instrument for voice-related quality of life (V-RQOL).
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GRBASI’s scale assesses the global impression of 
dysphonia (G) considering hoarseness (R), soprosity (B), 
asteny (A), tension (S) and instability (I), which are scored 
0 to 3, 0 (no change), 1 (mildly altered), 2 (moderately 
altered) and 3 (severely altered). V-RQOL is a protocol 
whereby patients relate their voice to quality of life in a 0 
to 100 score where 100 is improved quality of life35,36. In 
a general voice assessment, patients classify their voice in 
a 0 to 5 scale where 0 is impaired voice and 5 is normal 
or near normal voice.
Computer analysis was made based on open and 
isolated phonation of the sustained vowel /e/ picked up by 
an AKG model C410 professional microphone at a standard 
5 cm distance from the patient. Voice recording was done 
by the Computerized Speech Lab - CSL, model 4300B, and 
analyzed by the Kay Elemetrics Corp.’s MDVP (Multi-Di-
mensional Voice Program) voice analysis program.
Each patient was asked to emit an isolated and 
sustained vowel /e/. A voice sample was considered as 
the most stable 3 second period, whenever possible elimi-
nating the beginning and the end of sound emission or a 
maximum period of voice stability. The following acoustic 
measurement parameters were used in this study: funda-
mental frequency, the perturbation quotients Jitter (varia-
tions of frequency) and Shimmer (variations of amplitude), 
and noise measurements (harmonics-to-noise ratio).
Computer analysis compared fundamental fre-
quency, jitter, shimmer, and harmonics-to-noise ratio with 
a patient control group (average age 57.6 years) that had 
normal larynxes, and no complaints about voice.
Videolaryngostroboscopy was used to analyze the 
following parameters:
1. Glottic coaptation: complete or incomplete
2. Laryngeal vestibule constriction: normal or with 
hyperconstriction.
3. Presence of vibration: absent, glottic, supraglottic 
or combined. Vibration was considered as absent if there 
was any area of akinesia in the resected glottic region, 
with no supraglottic compensation.
The Stata 7.0 program was used for statistical 
analysis. Data had a normal distribution allowing us to 
use Student’s t-test for non-related samples to compare 
numerical data in the study and the control groups. The 
significance level was 0.10.
RESULTS
Student’s t-test was used to compare the average 
fundamental frequency of males in the study group and 
the control group (139.3Hz). The descriptive value was 
0.2008, which suggests no differences between both 
groups. There were not sufficient females in the study 
group to apply statistical tests. Descriptively, however, the 
226.24 Hz average value may be compared to the average 
control group value (202,23 Hz).
Student’s t-test for independent samples demon-
strated that average jitter in patients was higher than in 
the control group (p = 0.001), that average shimmer in 
patients was higher than in the control group (p = 0.0007), 
and that patients had a higher average harmonics-to-noise 
ratio compared to the control group (p = 0.053).
DISCUSSION
There is no agreement about voice quality after dif-
ferent treatment strategies for glottic tumors, particularly Tis 
and T1 tumors. Important factors influencing the decision 
for a specific treatment procedure, except for voice quality, 
include oncological results, cost and morbidity.
There are few papers in literature assessing voice 
following CO
2
 laser cordectomy, and only rarely is there 
a comparison with a control group of normal individu-
als; there are no such papers published in Brazil to date. 
The importance of voice is evident as we measure voice 
changes in patients undergoing CO
2
 laser cordectomy 
compared to normal individuals and to how much this 
affects their lives. Furthermore, future comparisons may 
be made both within groups undergoing similar treatment 
and between groups subjected to other strategies such as 
radiotherapy and conventional surgery.
In our patients age ranged from 43 to 82 years 
(average 63.1 years), with 80% males. This is similar to 
other published studies, evidence that malignant laryngeal 
tumors are more frequent in men in the sixth and seventh 
decades of life1.
Although all patients were staged as Tis and T1a, 
the type of cordectomy varied in the group. Less extensive 
cordectomies, classified as type I and II, were done in 53% 
of patients. Type III and IV cordectomies were done in 
the remaining 47%.
Subjective analysis demonstrated that the majority of 
patients had some degree of dysphonia, usually hoarseness 
and soprosity. These results are not surprising, as hoarse-
ness (R) is related to vocal crepitation and bitonality due 
to irregular vibration of the vocal folds, and soprosity (B) 
Table 1. Results of the GRBASI scale.
Variable 0 1 2 3 total
G 3 3 4 5 15
R 5 3 4 3 15
B 3 3 6 3 15
A 12 2 1 0 15
S 12 1 0 2 15
I 6 4 4 1 15
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Table 4. Results of acoustic voice analysis in patients undergoing CO2 laser cordectomy, considering the type of surgery and a comparison 
with the control group.
Patient Type Fund. freq. (Hz) male Fund. freq (Hz) female Jitter% Shimmer% Ratio harm/noise
1 I  191,72 1,59 3,34 0,13
2 I 120,27  0,99 4,55 0,14
3 I  205,25 1,61 1,97 0,10
4 II 172,68  3,09 3,12 0,09
5 II 143,47  1,49 2,36 0,13
6 II 140,06  2,15 4,43 0,16
7 II 161,89  2,62 3,09 0,13
8 II 124,85  8,04 12,72 0,47
9 III  281,75 2,82 3,26 0,09
10 III 119,77  3,25 5,05 0,13
11 III 158,04  1,24 5,48 0,13
12 III 174,40  4,24 11,74 0,29
13 IV 226,67  5,89 15,99 0,44
14 IV 112,00  20,85 24,59 0,78
15 IV 356,00  5,97 15,24 0,60
 Average 167,51 226,24 3,18 7,79 0,25
 Average Control 139,30(p=0,2008)  202,23 0,76(p=0,001) 3,95(p=0,0007) 0,13(p=0,053)
Table 3. V-RQOL (voice and quality of life) protocol scores, related to 
the type of cordectomy.
Patient Type V-RQOL
1 I 90,0
2 I 87,5
3 I 100,0
4 II 97,5
5 II 100,0
6 II 87,5
7 II 87,5
8 II 65,0
9 III 100,0
10 III 95,0
11 III 92,5
12 III 67,5
13 IV 90
14 IV 85
15 IV 77,5
 Average 88,17
Table 2. Patient distribution considering the general voice assessment 
and the type of cordectomy (0 is impaired voice and 5 is normal or 
near normal voice).
General assessment
 Patient 1 2 3 4 5
Type I or II
1     √
2     
3    √  
4     √
5     √
6    √  
7     √
8  √    
Type III or IV
9    √  
10     √
11     √
12   √   
13   √   
14  √    
15   √   
is related to air escape during phonation. One naturally 
expects a scar and local irregularity when cordectomy is 
done, as part of the vocal fold is removed.
Patient opinions about their voice following treat-
ment were also of interest in this study. Using Sittel et al’s 
(1998)33 scale, six patients (40%) who judged their voices 
as normal or near normal, four patients (26.7%) judged 
their voices as good for communicating but pathological, 
three patients (20%) judged their voices as reasonable, 
and only two (13.3%) judged their voices as impaired, 
but understandable. No patient classified their voice as 
very dysfunctional.
The impact of voice on the patient’s quality of life 
should be a constant concern in the treatment of laryngeal 
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Table 5. Videolaryngostroboscopic images, considering the type of cordectomy.
Patient Type Coaptation Constriction of vestibule Presence of vibration
1 I Complete Normal Glottic
2 I Complete Normal Glottic
3 I Incomplete Normal Glottic
4 II Complete Normal Combined
5 II Complete Normal Glottic
6 II Incomplete Normal Combined
7 II Complete Normal Combined
8 II Complete Hyperconstriction Supraglottic
9 III Incomplete Normal Absent
10 III Complete Normal Glottic
11 III Incomplete Hyperconstriction Glottic
12 III Complete Hyperconstriction Absent
13 IV Incomplete Hyperconstriction Absent
14 IV Complete Hyperconstriction Absent
15 IV Incomplete Hyperconstriction Supraglottic
tumors. This concept, however, is recent; Zeitels (1995)12 
states that the current standard of phonomicrosurgery is to 
obtain oncological radicality with voice quality that causes 
the least change in quality of life. Classical assessments of 
health treatment valued only the presence or absence of 
disease following treatment, which is important, but insuf-
ficient to assess the impact on life in general37. O V-RQOL 
was developed specifically to correlate how much voice 
change may affect the patient’s quality of life36. In this study 
the average V-RQOL was 88.17. These results show that 
although most patients undergoing CO
2
 laser cordectomy 
had some degree of dysphonia, the effect on activities of 
daily life was minor. It is important to underline that no 
patient in this study used his or her voice professionally, 
which reduces the impact of voice changes on the qual-
ity of life. In fact, the V-RQOL is not a sensitive method 
to assess professional voice users36, as minor changes in 
a singer, for instance, may compromise his or her career, 
whereas the same change in a person that does not use his 
or her voice professionally may cause minimal impact.
Stoeckli et al (2001)38 used the EORTC QLQ-C30 
quality of life questionnaire and the head & neck module 
(EORTC QLQ-H&N35) developed by the European Organi-
sation for Research and Treatment of Cancer for patients 
with early laryngeal tumors treated with radiotherapy and 
CO
2
 laser surgery. Results confirm good quality of life in 
both treatment strategies. Specific head & neck question-
naire questions about swallowing solid food, xerostomy 
and dental problems scored worse for patients undergoing 
radiotherapy, although there was no difference in voice 
quality. Schneider, Guidicelli & Stöckli in 200039 have also 
described similar results.
Computer voice acoustic analysis using the Kay 
Elemetrics Corp. Computerized Speech Lab-CSL model 
4300 MDVP (Multi-Dimensional Voice Program) voice 
analysis program showed that, except for the fundamental 
frequency, all voice acoustic analysis parameters in this 
study - percentage of jitter and shimmer, and harmon-
ics-to-noise ratio - are significantly affected by CO
2
 laser 
cordectomy (p<0.1) comparing results of the surgery group 
to controls.
The average fundamental frequency for operated 
male patients was higher compared to controls, although 
this difference was not statistically significant. There were 
not sufficient females in the study group to apply statistical 
tests, but a minor increase of 24.01 Hz in the fundamental 
frequency was seen compared to controls (202.23Hz). 
Similar results have also been reported by McGuirt et al. 
(1992)31 with a slightly higher average fundamental fre-
quency compared to a normal control group. Voice tends 
to become more acute due to the removal of tissue and 
resulting compensation mechanisms. The main factors af-
fecting the fundamental frequency are the length, mass and 
tension of the vocal fold; the lower the mass, the higher 
the frequency. Furthermore these patients frequently com-
pensate with hyperconstriction and tension which can also 
increase the fundamental frequency.
Both jitter and shimmer were significantly higher 
in the study group compared to controls. These results 
reflect increased aperiodicity in the glottic cycle and 
sound wave variability. The harmonics-to-noise ratio is 
directly related to voice quality36. It analyzes aperiodic 
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components of sound and is considered a good correlate 
to what we consider as dysphonia. The study group aver-
age was higher compared to controls and was statistically 
significant (p = 0.053).
Results of objective voice analysis clearly suggest 
that voice quality in patients undergoing CO
2
 laser cor-
dectomy is compromised compared to individuals with 
no voice-related problems. A further issue is that when 
these patients seek medical help, they already have some 
degree of dysphonia by having a glottic tumor. Pre-opera-
tive voice assessment was not evaluated in this study, but 
is suggested for future studies.
Theoretically, regardless of the treatment, voice 
quality of patients with glottic tumors will never be equal 
to their voice before the disease. Even the smallest cordec-
tomy will involve resection of part of the mucosa, reducing 
the ability for vibration at that point.
Although considered a more conservative strategy, 
radiotherapy also has negative effects on voice quality 
compared to controls40. Hocevar-Boltezar et al. (2000)41 and 
Dagli et al. (1997)42 also found increased jitter and shimmer 
values and a higher fundamental frequency compared to 
controls in irradiated patients assessed objectively. Such 
results may be explained by post-radiation vocal fold 
fibrosis and rigidity in both sides.
Videolaryngostroboscopy found that 75% (n=6) of 
patients undergoing type I and II cordectomy presented 
complete glottic closure. In this same group glottic mucosal 
vibration was always present; only 1 patient (individual 
number 8) had supraglottic vibration. This same patient 
was the only one in this group (cordectomy types I and 
II) that had laryngeal vestibule hyperconstriction. All 
subjective and objective parameters in this patient, except 
for the fundamental frequency, were worse compared to 
other patients in the same group. A further interesting 
point is that even in type II cordectomy, glottic closure 
was complete in 4 of the 5 operated patients. This is rel-
evant because voice quality is intimately related to glottic 
closure. Frequently in situ carcinoma is treated with type 
I cordectomy, and the surgeon may find himself surprised 
with the pathological examination showing compromised 
surgical resection margins. The next step would be to 
widen the surgical margins, which means the patient has 
to undergo a second operation or be referred to radio-
therapy. Knowing that the post-operative functional result 
is similar in type I and II cordectomies, a safer and wider 
margin procedure for Tis could be advised.
Videolaryngostroboscopy of type III and IV cor-
dectomies showed that 57.1% (n=4) of patients presented 
incomplete glottic closure, an increased trend to have 
laryngeal hyperconstriction as a compensation mechanism 
and no mucosal vibration. Stroboscopic changes correlated 
with voice quality data in study group patients, probably 
due to the amount of tissue removed, decreased mucosal 
vibration and compensation mechanisms.
Although results suggest that patients undergoing 
CO
2
 laser cordectomy have abnormal voice parameters, 
the possibility of preserving communication is itself reason 
for satisfaction. Frequently patients lose motivation when 
receiving a diagnosis of cancer of the larynx, believing 
that treatment is necessarily related to voice loss, which is 
so important for social interactions. Expectations of voice 
professionals may not be reached, but this is not what 
happens to most patients; they frequently surprise us by 
being satisfied with their resulting voice quality.
CONCLUSION
Voice perceptive-auditory analysis indicates that 
most patients undergoing CO
2
 laser cordectomy presented 
some degree of dysphonia, usually hoarseness and so-
prosity.
Both the general voice assessment made by patients 
and the quality of life protocol scores suggest that CO
2
 
laser cordectomy produces acceptable functional results, 
with minor repercussion on the patient’s lives.
Acoustic voice analysis showed a minor increase in 
the fundamental frequency of operated patients compared 
to controls. This difference was not statistically signifi-
cant. Worse jitter, shimmer and the harmonics-to-noise 
ratio results were seen in patients undergoing CO
2
 laser 
cordectomy.
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